Mangalam Drugs And Organics Limited — Results, 25-02-2025: Integrated Filing- Financial

Mangalam Drugs and Organics Limited has announced a board meeting to review the financial results for the quarter and nine months ended December 31, 2024. The unaudited results show a total income of ₹88.71 crore for the quarter, compared to ₹97.34 crore in the same period last year, reflecting a decrease in sales. Notably, the net profit after tax for the quarter is ₹14.03 crore, a turnaround from a loss of ₹12.60 crore in the previous nine months. This improvement suggests operational recovery and could enhance investor sentiment, presenting a positive outlook amid ongoing challenges in revenue generation.